Access cutting-edge al amyloidosis treatment through this clinical trial at a research site in Buffalo. Study-provided care at no cost to qualified participants.
Access al amyloidosis specialists in Buffalo at no cost
This study follows strict safety protocols and ethical guidelines
All study-related al amyloidosis treatment provided free
This study is researching an experimental drug called linvoseltamab ("study drug"). This study is focused on patients who have AL amyloidosis that has returned or have failed other therapies and need to be treated again. The study consists of 2 phases (Phase 1 and Phase 2): * In Phase 1, linvoseltamab will be given to a small number of participants to study the side effects of the study drug and to determine the recommended doses of the study drug to be given to participants in Phase 2. * In
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this al amyloidosis clinical trial in Buffalo, NY
If you're searching for al amyloidosis treatment options in Buffalo, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Buffalo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced al amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.